Somethings not consistent here with your numbers @manuva13 as LBT is ascribing a financial payback of ~2.2 years which once converted to AUD means savings of say A$200k per annum for the average size lab. Most labs work on financial year capital budgets - imo that’s the issue we’re facing here in explaining any delay in sales. If a lab ain’t got budget this year they cannot buy.
Outcome from JP Morgan conference?, page-22
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
0.002(12.5%) |
Mkt cap ! $31.63M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.8¢ | 1.7¢ | $3.899K | 228.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 361155 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 1523195 | 7 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| LBT (ASX) Chart |